The pharmaceutical sector loses billions of dollars annually due to logistical failures including temperature excursions and a lack of end-to-end visibility.
The rapid shipment of vaccines worldwide to tackle Covid-19 highlighted the need for transport containers that adequately protect the medicines they are delivering. Since the pandemic began in 2020, additional factors such as a rise in demand for temperature-sensitive medicines, natural disasters and geopolitical factors have led to greater risk throughout supply chains, making them more vulnerable than ever before.
This Pharma Logistics IQ report, produced in association with SkyCell, dives into the shipping solutions pharma businesses can deploy to safely deliver temperature-sensitive medicines, analyzing the benefits of hybrid containers in pharmaceutical supply chains.
Download this report to find out about:
- The current challenges to delivering temperature-sensitive products.
- Hybrid container solutions and their benefits
- How to reduce environmental impact in the supply chain